This article is more than 5 years old. Information may no longer be current.
THINK Surgical gains FDA clearance to market active robot for total knee replacement
Click Here to Manage Email Alerts
THINK Surgical Inc. announced FDA approval to market its active robot, TSolution One Total Knee Application, for use in total knee replacement.
“What will be particularly appealing to surgeons is the open implant library offered by this active robotic system, which can achieve an optimal personalized surgical plan for each patient. This innovative system will revolutionize the treatment of end-stage knee arthritis by coupling an individualized plan with precise bone-cutting technology,” Bernard Stulberg, MD, orthopedic surgeon and principal investigator in this product’s clinical study, said in a THINK Surgical press release.
According to the release, this active robotic system includes CT-based 3D pre-surgical planning software that allows surgeons to virtually design and prepare patients’ joint replacement plans. During the replacement surgery, the surgeon implements the pre-planned procedure using the robot, which prepares the joint according to the plan.
“We are thrilled to expand the use of this state-of-the-art technology, which is truly transforming orthopedic surgery,” John Hahn, CEO and president of THINK Surgical, said in the release. “U.S. FDA clearance of TSolution One furthers our commitment to improving the lives of patients suffering from severe osteoarthritis by expanding the global commercialization of our active robot for TKA.”
Reference: